National Cancer Institute (NCI) director, Dr. Ned Sharpless, has announced he intends to leave his post at NCI at the end of April. Dr. Sharpless has led the Institute for five years during which time he proved to be a tireless advocate for increased investment in cancer research.
WASHINGTON, D.C.— Monday the Biden administration released its FY 2023 budget, which includes $5 billion for the forthcoming creation of the Advanced Research Project on Health (ARPA-H) but reduces funding by nearly $200 million for the National Cancer Institute (NCI); a scenario
This Wednesday will mark 12 years since the Affordable Care Act was signed into law and cancer patients, survivors and millions of others gained expanded access to comprehensive health coverage.
This Wednesday will mark 12 years since the Affordable Care Act was signed into law and cancer patients, survivors and millions of others gained expanded access to comprehensive health coverage.
Tobacco use rates among US adults hit an all-time low, but rates remain high among certain populations according to data released by the Centers for Disease Control and Prevention today.
The cost of cancer care is substantially impacting the lives of cancer patients and survivors, forcing them to make significant lifestyle changes, and causing some to incur long-term medical debt.
A new survey released today from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) finds youth tobacco use remains a serious public health threat.
Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.
Advocates are pushing Congress to increase cancer research funding at that National Institutes of Health (NIH), National Cancer Institute (NCI) and to fund the president’s proposal to create the Advanced Research Project on Health (ARPA-H) as part of the FY 2022 federal budget.
The Food and Drug Administration (FDA) today authorized the marketing of two low-nicotine cigarettes as “modified risk tobacco products,” including one product that is menthol-flavored.